Two Decades of the Gaming Chair: How DXRacer Defined an Industry and Transformed Modern Ergonomics

WHITMORE LAKE, MI, UNITED STATES, February 5, 2026 /EINPresswire.com/ -- In 2006, the landscape of competitive gaming ...

Robot Industries establishes RiA Ecosystem Manager as the orchestration layer for multi-brand and autonomous systems

Robot Industries GmbH today announced the establishment of RiA Ecosystem Manager, a unified platform designed to ...

2025 Tech Trends: RecPoint Note and Industry Leaders Redefine Human Productivity Through Specialized AI Terminals

The Democratization of Manufacturing: Desktop Factories ...

ACS Introduces Customizable PET Film Solutions to Enhance Product Durability and Aesthetics

FOSHAN, GUANGDONG, CHINA, January 28, 2026 /EINPresswire.com/ -- In the modern industrial design landscape, the ...
Ahmedabad Mirror

Paradigm Realty Elevates High-Rise Living in Mumbai with the Unveiling of an Ultra-Luxury Double-Height Lobby at Anantaara in Borivali West

Paradigm Realty Elevates High-Rise Living in Mumbai with the Unveiling of an Ultra-Luxury Double-Height Lobby at Anantaara in Borivali West ...

China Top 10 PC Polycarbonate Lens Manufacturer YOLI: Key Offerings At Vision Expo East

DANYANG, JIANGSU, CHINA, January 22, 2026 /EINPresswire.com/ -- The global optical sector is currently witnessing a ...

Myopia is driven by how we use our eyes indoors, new research suggests

For years, rising rates of myopia—or nearsightedness—have been widely attributed to increased screen time, especially among ...
Security Info WatchOpinion

Deepfakes at Scale: Why Digital Trust Is Collapsing and How Organizations Must Respond

Deepfake-driven attacks have surged more than 1,000% globally, turning social engineering into a precision AI weapon. In a ...
foxbangor.com

Study suggests short-sightedness caused by how we use our eyes indoors

The common condition - also known as myopia - may be driven less by screens and more by a common indoor visual habit.

Ocular Therapeutix, Inc. (OCUL) Discusses Positive Top Line Results From SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD Transcript

Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...